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For decades, the citizens of Libby,
Montana, knew something was awry in their
rural community. Every year, more and more
residents were developing respiratory prob-
lems such as emphysema and mesothelioma.
The problems often became fatal. In fact, by
fall 2000, there were more than 190 such
deaths by some estimates. Residents had long
suspected a vermiculite mine, the town’s chief
employer for nearly 70 years, as the source of
the maladies. Yet, no one knew for sure.
In November 1999, the federal govern-
ment investigated. Besides vermiculite, the
mine, which was shuttered in 1990, was found
to have released tons of tremolite–actinolite
into the environment during operations.
Tremolite–actinolite, naturally occurring
mineral fibers, are rare and highly
toxic forms of asbestos, and
exposure can manifest
decades later in chronic
respiratory diseases such
as asbestosis, emphyse-
ma, and rare cancers. 
As far back as the
mid-1950s, state health
officials had reported the
presence of toxic asbestos
dust in the mine, but no
one had followed up to study
possible exposures or health
effects on the town’s residents.
According to investigators from
the Agency for Toxic Sub-
stances and Disease Registry
(ATSDR), the mine may be
the most significant single source of toxic
asbestos exposure in U.S. history.
Situations like the one in Libby reveal that
there are serious flaws in the way the United
States approaches environmental health. And
monitoring of human exposure to environ-
mental agents is often the weakest component
of environmental health work, severely limit-
ing risk assessment capabilities.
Across key government agencies, experts
agree that current efforts to monitor human
exposure to environmental agents are inade-
quate. Good data on the type, pattern, and
magnitude of human exposures are in short
supply. A series of recently released reports by
private and public institutions support such
assertions and, coupled with a rising incidence
of chronic diseases from asthma to lupus, are
spurring calls for systemic improvement.
Not Enough Data
“The bottom line in exposure tracking is that
we know very little about what the
public is being exposed to or the
actual levels of the exposure.” So
concludes America’s Environ-
mental Health Gap: Why the
Country Needs a Nationwide
Health Tracking Network,
released in September 2000
by the Pew Environmental
Health Commission at the
Johns Hopkins School of
Hygiene and Public Health in
Baltimore, Maryland.
Chemical exposures is one
arena where data are sorely lacking.
Together, the leading national
exposure assessment surveys—
run by the Department of
Health and Human Services
and the U.S. Environmental Protection
Agency (EPA)—monitor exposure to a mere
6% of the 1,400 potentially hazardous high
production volume (HPV) chemicals in com-
mon use, finds a May 2000 General
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Exposure is
the wasteland
of risk assessment
because we tend to rely
on default assumptions
when we don’t have
methodologies
or information.
—Carol Henry
Vice President 
of Science and Research
American Chemistry Council Accounting Office (GAO) report titled Toxic
Chemicals: Long-Term Coordinated Strategy
Needed to Measure Exposures in Humans.
(With a total of 2,800 such chemicals, HPV
chemicals are those that are produced or
imported at volumes of one million or more
pounds per year.) Moreover, states the report,
the information obtained is often insufficient
to identify smaller populations at high risk. To
compound difficulties, no laboratory method
has been developed for measuring concentra-
tions of most chemicals in human tissues.
Furthermore, even if measured accurately,
would scientists know the significance of the
measurement?
“Society spends an enormous amount of
money on monitoring the environment—on
water utilities alone we spend more than a bil-
lion dollars—but we have not adequately
looked at exposures to the human popula-
tion,” says Richard Jackson, director of the
National Center for Environmental Health at
the Centers for Disease Control and
Prevention (CDC) in Atlanta, Georgia.
Although some federal programs are see-
ing expansion, “there’s a real lack of quality
exposure information,” says toxicologist Scott
Masten, who heads the NIEHS Office of
Chemical Nomination and Selection. “And
without it, you can’t put toxicology data in
perspective, and thus you can’t really say
much about health risks.”
Traditionally, estimates of human expo-
sure to known or perceived environmental
toxicants have been made on the basis of con-
centrations of agents found in air, water, and
food. Assumptions are then made about how
much gets into people’s bodies. But such
assumptions have often proven problematic.
For example, explains Michael Kleinman, a
professor of community and environmental
medicine at the University of California at
Irvine, “When we go from emissions data to
exposure assessment, we are forced to use con-
servative assumptions and as a result are com-
ing up with calculations that are alarming but
are really only good guesses. In some cases,” he
says, “the actual exposures could be that high,
but right now we could be alarming people
unnecessarily.”
The newly emerging field of exposure
assessment strives to specifically determine
who is exposed, how the exposure occurs—
whether through inhalation, ingestion, skin
contact, or other routes—and how much
exposure occurs, and for how long and how
often. Although the technology has not yet
been widely applied, direct biologic monitor-
ing of human exposure to chemicals has
become increasingly accurate due to recent
advances in molecular biology and analytic
chemistry. “Today, unlike a decade ago, the
technology has evolved to a point where
researchers can do good exposure analysis,”
says Judith Graham, associate director of the
EPA’s National Exposure Research Laboratory
in Research Triangle Park, North Carolina.
But, she adds, “Exposure assessment is still
tough to do.” Adds EPA scientist Linda
Sheldon, “We’re somewhere between crawling
and walking.” 
For starters, experts explain, the science of
exposure assessment is complex. Multiple pol-
lutant sources, pathways, time frames, and
mixed and cumulative doses must all be fac-
tored in. And to do exposure assessment well,
many disciplines must be integrated, including
toxicology, epidemiology, and exposure analy-
sis. Further complicating things, both finan-
cial and infrastructure resources are limited, as
most U.S. environmental laws don’t mandate
exposure assessment. The number of people
trained in exposure assessment is a limiting
factor: Jackson’s labs at the National Center
for Environmental Health rely on roughly 70
scientists for their exposure assessment activi-
ties, and the ATSDR has only 9 investigators
in its specialized exposure assessment unit.
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The source of the problem. Very little is known about exactly what types of envi-
ronmental agents people are exposed to from sources such as air, water, and food,
and in what amounts.
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to the public, industry, and researchers alike,
especially as recognition grows that environ-
mental factors—both chemical and socioeco-
nomic—play a stronger role in cancer and
other illnesses than previously thought.
“Exposure assessment is very difficult, very
complex, and very expensive, but probably
what we should be doing more of,” Masten
says. Paul Lioy, deputy director of the
Environmental and Occupational Health
Sciences Institute in Piscataway, New Jersey,
adds, “When we develop new regulations or
call on current regulations, we need to invoke
the concept of not only monitoring the envi-
ronment but also trying to monitor exposure.”
Sheldon acknowledges the steep price of
good data, but notes that policies based on
good exposure assessments can save billions of
dollars. One the one hand, she says, harmful
exposures can be minimized, preventing ill-
nesses and reducing health care costs; on the
other, knowledge that an exposure is not
harmful can prevent unnecessary and expen-
sive mandates for revising industry practices.
The CDC’s Role
As one of the leaders in the field of exposure
assessment, the CDC manages the National
Health and Nutrition Examination Survey
(NHANES), a broad-based snapshot of nutri-
tion and health that now examines a new,
nationally representative sample of 5,000
Americans each year. Exposure assessment is
only one component of NHANES, however,
accounting for about $5 million of the study’s
annual budget, Jackson explains.
NHANES has come a long way since
1960, when researchers at the CDC began
periodically conducting interviews and making
physical assessments of cohort participants,
including collecting blood and urine samples
for detecting everything from hypercholes-
teremia to diabetes. In 1976, researchers began
measuring exposure to selected chemicals and
banking the samples for future reference. In
1999, NHANES became an annual survey.
Previous iterations of NHANES ran 4–6
years, and researchers sometimes had to wait
up to 10 years after data collection to gain
access to results for the entire 6-year sample.
Now that NHANES will be conducted on a
yearly basis, researchers plan to release data
annually beginning in 2002.
NHANES has already successfully helped
policy makers create and evaluate intervention
policies. For example, early survey data on
blood lead concentrations provided the first
clear-cut indication that Americans had too
much lead in their blood, prompting Congress
to enact policies to remove lead from gasoline.
In turn, blood lead data gathered between
1976 and 1990 indicated that the ban on lead-
ed gasoline had proven effective, Lioy says.
NHANES data have also helped profile expo-
sure to environmental tobacco smoke in sup-
port of smoking reduction measures. 
The current NHANES effort tracks a
broader range of environmental exposures
than ever before. The results will offer new
insights into individual exposure levels to over
100 substances, including metals, pesticides,
and dioxins. Also on the NHANES agenda
will be a broad range of contaminants from
consumer products, dietary exposures, and
industrial emissions. Yet, many public health
practitioners would like to see NHANES
expanded even more, according to Jim
O’Hara, executive director of Health-Track, a
new Georgetown University–based Pew
Commission project to help establish a nation-
al tracking and monitoring system for environ-
mental health.
NHANES has only limited utility for
tracking exposures at the state and local level,
however. The September Pew Commission
report reveals that most public health practi-
tioners are unable to address fundamental
community concerns because of their limited
means for measuring and evaluating actual
levels of exposure. Many have outmoded
equipment and information systems, and lack
technical and lab support. Although 75% of
public health practitioners do track blood lead
concentrations, biomonitoring for other sub-
stances, including hazardous pesticides, is
minimal. Only about one-quarter can mea-
sure human exposure to environmental conta-
minants by monitoring the air in a person’s
breathing zone, the Pew Commission report
finds. And even when officials can collect data
on internal exposures, says the GAO report,
they often lack the knowledge and resources
needed to interpret those data.
As part of the latest NHANES study, the
CDC’s National Center for Health Statistics is
developing a smaller, more targeted survey
called the Defined Population National
Health and Nutrition Examination Survey.
This survey will collect information that will
be directly useful at the local and state level by
offering feedback that can guide communities
in protecting their residents. The survey will
be conducted using small mobile examination
centers to visit areas of interest and monitor a
total of 2,000–3,000 participants. 
At present, much of the CDC’s work on
exposure is focused on developing robust test-
ing methods for detecting exposures in
humans. The process for developing a test
method for even a single chemical can be
tedious and costly. “Sometimes it takes six
months to figure out [a detection method],”
Jackson says. And usually there is no help
from the commercial sector, as there is little
industrial need or economic incentive to
develop these types of tests, which can often
detect concentrations in the parts-per-billion,
-trillion, and even -quadrillion range in small
samples of less than 10 milliliters. “The ability
to measure many toxic agents in extremely
small specimens is not merely an acrobatic feat
of technical virtuosity but in fact critical,”
Jackson says—otherwise, actual exposures
may go undetected. 
The CDC is also developing methods to
detect exposures in real time, to evaluate
evanescent exposures (those that wash out of
the body relatively quickly), and to handle
high volumes of samples efficiently. Currently,
researchers must often rely on subjects’ memo-
ry—which is frequently inaccurate—to gauge
exposures. Better human exposure assessment
will bring new precision and power to environ-
mental studies, Jackson says, and help public
health practitioners get services to the individ-
uals who need them most.
In winter 2000, the CDC plans to release
the first National Exposure Report Card. The
report card will list levels of different toxicants
in the population at large, measured either
directly or through study of metabolites. The
first report card will assess 25 substances in
3,000 individuals enrolled in the current
NHANES. Blood concentrations of metals
such as lead, mercury, and cadmium, as well as
cotinine, a marker of exposure to tobacco
smoke, will be measured. In a smaller group of
about 1,000 study participants, urine concen-
trations of organophosphate and phthalate
metabolites and other substances will be stud-
ied. By 2003, the report card will be expanded
to 100 chemicals and could eventually moni-
tor even more, says Julie Fishman, a CDC
health policy analyst. 
The CDC’s National Institute for
Occupational Safety and Health (NIOSH) is
also planning a new initiative to better charac-
terize occupational exposure through a
national, cross-sectional, on-site survey of
establishments and workers. The new survey
will include industry sectors covered by the
Occupational Safety and Health Admin-
istration and the Mine Safety and Health
Administration. (For example, worker expo-
sure to cellulose insulation and to asphalt
fumes are two areas already under evaluation
in an interagency collaboration between
NIOSH and the NIEHS.) With input from
the NIEHS and other federal agencies, the
survey will build upon NIOSH projects such
as the National Occupational Exposure
Survey and the National Occupational Health
Survey of Mining to develop an occupational
exposure database. 
The EPA and Exposure Assessment
While the CDC uses NHANES to tell
researchers whether exposure to a particular
chemical has occurred and how many people
have been exposed, the EPA strives to under-
stand the population distribution of exposure
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susceptible populations, through a variety of
exposure measurement studies. The EPA is
also working to identify the sources and path-
ways of excessive exposures so that the sources
can be controlled.
The National Exposure Research
Laboratory has been working for over a
decade to develop the tools and framework for
the National Human Exposure Assessment
Survey (NHEXAS). NHEXAS is a geographi-
cally based exposure measurement program
designed to provide information on the mag-
nitude and extent of populations’ exposures
via air, water, soil, and food, and to inform
the risk assessment and risk management
processes established to protect public health. 
In the early 1990s, to evaluate the feasibil-
ity of such a survey and generate data on the
levels and determinants of exposure, an intera-
gency pilot study program for NHEXAS that
included the EPA, the CDC, and the Food
and Drug Administration was begun. The
pilots are population-based surveys of some
460 people in three geographic areas in the
United States. Exposure monitoring data have
been collected for metals, pesticides, volatile
organic compounds, and other chemicals—
about 46 agents in all. Researchers have mea-
sured the agents in the air people breathe, the
foods and beverages they consume, and the
soil and dust in and near their homes,
Graham says. Blood and urine samples have
been scrutinized for trace chemicals, and the
participants have also filled out questionnaires
to identify exposure sources and behaviors
that could affect exposure. To date, the
NHEXAS pilots have cost about $20 million. 
The NHEXAS pilots have clearly
advanced the nation’s ability to measure indi-
vidual exposures to environmental pollutants.
They provide the largest multimedia, multi-
pathway, multichemical database of its kind,
Graham says. But the project, intended only
as a pilot, naturally falls short of current
demands. By design, the NHEXAS pilots are
cross-sectional, not longitudinal, which means
they can’t track trends in population exposure,
the GAO report observes. Moreover, the pro-
ject only covered certain pollutants in three
geographic areas.
Perhaps the most important limitation of
NHEXAS, the GAO report says, is that initial
funding was inadequate to complete a full
analysis of findings and make data available to
researchers, policy makers, and the public.
Finally, NHEXAS is not linked to any ongo-
ing health surveillance because steps to estab-
lish a direct linkage between environmental
exposures and health were not included in the
design. To complete a national exposure sur-
vey that would include such links, the EPA
estimates a cost of $30 million a year for a
decade or more.
NHEXAS is just one of the EPA’s tools to
better understand the exposures faced by the
American public. The agency’s Border XXI
studies seek to quantify hazardous exposures
for children living along the U.S.–Mexico
border, placing an emphasis on pesticide
exposures. The Children’s Total Exposure to
Pesticides and Other Persistent Organic
Pollutants study, the first large multipollutant,
multimedia study of young children, is char-
acterizing exposure pathways in more than
250 children ages 2–5 in homes and day care
centers. The Pesticide Exposure Study, a large
interagency epidemiologic collaboration, is
assessing pesticide exposure factors among
men and women in agriculture participating
in the Agricultural Health Study. And the
Particulate Matter Exposure Studies are look-
ing at sources and variability of exposures to
particulate matter in different subpopulations,
including the elderly, those with cardiopul-
monary disease, and African Americans. To
date, these studies have monitored about 150
people in various areas of the country, repre-
senting various air sheds and housing struc-
tures, for more than 2,000 person-days.
The National Exposure Research
Laboratory also works with the EPA’s National
Health and Environmental Effects Research
Laboratory, also located in Research Triangle
Park, to link exposures to health outcomes.
Such information is critical for populations
who are more sensitive to chemical exposures
or more likely to have high exposures, Graham
says. The elderly and children, for example,
may be harmed by low-level exposures that
pose no risk to the general population.
Individuals who are genetically more suscepti-
ble or immunocompromised may also face a
greater risk. The concentration of exposure,
however, can also be a factor in the develop-
ment of disease among the population at large.
A major use of the EPA’s data is to devel-
op scientifically sound exposure assessment
techniques for application in the risk assess-
ment process. “Exposure monitoring data are
also indispensable for the success of epidemio-
logic research, to determine the status and
trends of exposures in populations, and for the
development and evaluation of risk manage-
ment activities,” Sheldon says.
Graham acknowledges that progress in
deciphering NHEXAS data has been slow.
“The data analyses from NHEXAS are very
fresh,” she says. “They have not been available
long enough to be used directly by the EPA.”
But Graham expects to see increasing use for
risk analysis tools as more analyses are com-
pleted. So far, more than 20 published articles
have resulted from the study.
Application of NHANES data to risk
assessment has been improving steadily, and
more data are being factored in to analyses
that characterize risk. Most experts agree,
however, that overall the federal sector needs
to improve communication of exposure assess-
ment data to the public. Besides taking a long
time—sometimes years—to disseminate study
results, many agencies need to work on pack-
aging the data for the public. “Oftentimes, the
data that are released are not put out in a way
people can interpret well,” Kleinman says. For
example, in the past, charts that have been
released relay information about hazards only
and fail to represent actual exposures, need-
lessly alarming communities. “We need to do
a better job of communicating risk for an
area,” says Kleinman.
Moreover, the information has to be what
the public wants. Often, the public wants
information that is different from what scien-
tists are interested in. “We need to make sure
the community is involved in decisions
[regarding research directions],” Masten says.
“This is not just about scientists in a vacuum.” 
Federal and public health researchers alike
believe the utility of both the NHANES and
NHEXAS data sets would be substantially
improved if more emphasis were placed on
collecting long-term exposure data and
understanding childhood exposures. Ideally,
EPA and Department of Health and Human
Services administrators would like to initiate a
birth cohort and children’s longitudinal study
analogous to the Framingham Heart Study,
which has followed cardiac health in a New
England cohort for the past 42 years. This
ideal study would use noninvasive monitor-
ing methods (such as urine sampling), which
can greatly enhance the success of such stud-
ies, because it is easier to recruit and retain
children for study without the threat of fre-
quent needle sticks. In addition, noninvasive
procedures allow for more frequent collection
of data.
Pulling In Other Agencies
In 1996, the NIEHS joined in and began con-
ducting more focused activities in the human
exposure arena. In collaboration with the
CDC, the institute developed the Human
Body Burden Project, collecting human expo-
sure data to study human tissue concentrations
of environmental contaminants including hor-
monally active agents commonly called
endocrine disruptors. The project is part of the
institute’s larger human exposure assessment
initiative, which is designed to help prioritize
chemicals for further toxicity and carcino-
genicity testing and to aid in the interpretation
of National Toxicology Program toxicity stud-
ies by assessing actual human exposure levels,
says Masten. 
Each year, the National Toxicology
Program can evaluate only 10–20 of the
approximately 85,000 chemicals in com-
merce, so prioritization is essential. The
National Center for Environmental Health
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Extracting information. New methods are being devised to monitor the levels of environmental
contaminants such as chemicals, metals, and biological agents in people’s bodies.conducts the lab measurements for these stud-
ies, which have covered roughly 80 chemicals
to date. So far, most of the 200 human tissue
samples used for the studies were collected as
part of NHANES. Studies are currently under
way to better understand exposures to phytoe-
strogens (estrogen-like chemicals that occur
naturally in many plants and fungi) and phtha-
late esters (commonly used plasticizers).
Herbal medicines and drinking water disinfec-
tion by-products are potential areas for further
study under the National Toxicology Program. 
In addition to working with the CDC,
the NIEHS conducts numerous epidemiolog-
ic and clinical studies exploring the relation-
ship between exposures and disease. The
NIEHS shares the EPA’s goals of document-
ing exposures in children, identifying poten-
tially sensitive subpopulations, strengthening
the interpretation and use of animal toxicity
data, and refining risk assessments. Other
objectives include studying relationships
between health disparities and fiscal dispari-
ties, and establishing links between exposure
assessment data and the NIEHS Enviro-
nmental Genome Project, says Masten.
Meanwhile, the ATSDR conducts limited
exposure investigations, mainly carrying out
biomonitoring of hazardous waste sites for the
EPA. The ATSDR also studies environmental
exposures at the request of communities.
Currently, the agency’s staff of 70 are working
on about 55 projects, more than half of which
involve exposures stemming from Superfund
sites, reports Sharon Campolucci, the ATSDR
deputy director of health services. The assess-
ments appraise a few thousand self-selected
participants for manifestations of disease,
occupational history, and exposure history.
In 1995, the ATSDR created an exposure
investigation section within its Division of
Health Assessment and Consultation. Its
investigations typically entail collecting biolog-
ic samples, conducting personal monitoring
for site-related contaminants, and analyzing
environmental data. Although the studies have
proven useful for community outreach and
intervention, they generally involve fewer than
100 volunteers and are not intended to be
generalized to larger populations. So, although
such studies are valuable to the people they
study, they will not significantly help fill in the
exposure assessment gap on the national level.
Other pockets of exposure assessment,
though smaller in scale, are scattered across
several agencies. For example, the Food and
Drug Administration’s National Center for
Toxicological Research in Jefferson,
Arkansas, is developing animal testing meth-
ods to improve exposure assessment. And the
Consumer Product Safety Commission also
runs its own lab and does periodic exposure
assessments on adults related to specific
product testing. 
Spreading such investigations across agen-
cies plays to the expertise of different pro-
grams, but it also means exposure assessment
research is quite disjointed. For example, data
on exposure to a given chemical in soil may
reside with one agency, while data on exposure
to the same chemical in water reside with
another, and air exposures with yet another. In
large part this is because assessments are often
made in response to mandates and regulations.
Still, Lioy says, “We need better coordination
across agencies for how exposures match up
for air, soil, water, and food.”  
In fact, the nation’s need for a coordinated
federal strategy for monitoring human expo-
sures to potentially toxic chemicals is the chief
finding of the GAO report. Such a strategy
should link data collection efforts with agency
goals, needs, and expertise, as well as identify
at-risk populations and factor in states’ infor-
mational needs, the report says.
The findings came as no surprise to envi-
ronmental health practitioners and officials,
who have been working to coordinate intera-
gency efforts for years. In the mid-1990s, the
National Science and Technology Council’s
Committee on Environment and Natural
Resources made integrating and coordinating
environmental monitoring and research net-
works and programs across federal govern-
ment a priority. The committee recognized
that many such programs had single-agency or
single-resource focuses, and that chief among
such programs were exposure assessment initia-
tives. Last fall, the Committee on Environment
and Natural Resources advocated creating an
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from environmental contaminants and developing responsive regulatory
and legislative solutions.
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sinteragency coordinating body for exposure
assessment, and an informal committee is
already being assembled. 
Despite the realization that interagency
cooperation is crucial to accurate exposure
monitoring, progress has been slow until this
fall. In response to the concerns outlined in
the GAO report, the Department of Health
and Human Services and the EPA have creat-
ed an informal group to coordinate agency
activities, and a formal coordinating commit-
tee is to be named soon, Graham says.
Industry Lends a Hand
Industry, too, is evolving in terms of human
monitoring, changing both its role and its
image. The Rosslyn, Virginia–based Chemical
Manufacturers Association recently took a new
name: the American Chemistry Council
(ACC). With the new moniker come new and
strengthened initiatives, including several tar-
geting human exposure assessment and
improving communication of study data. For
example, this fall the ACC began funding for a
comprehensive chemical exposure framework
designed to characterize people’s exposures to
chemicals and reduce the guesswork involved
in quantitative estimates of exposure.
“Exposure is the wasteland of risk assess-
ment because we tend to rely on default
assumptions when we don’t have methodolo-
gies or information,” says Carol Henry, vice
president of science and research at the ACC.
“When it comes to the Toxics Release
Inventory [the EPA’s accounting of the chem-
icals released into the environment by indus-
try],” she says, “there is a tremendous amount
of uncertainty revolving around what the
actual health impacts are, and it will take a
huge amount of work to fix that.”
This year, the chemical industry launched
its Long-Range Research Initiative (LRI) as
part of a $1.2 billion ACC research campaign
to boost public confidence in chemical manu-
facturing. The program will be cofunded by
the European Chemical Industry Council and
the Japan Chemical Industry Association. The
International Council of Chemical
Associations will help oversee the project. 
The LRI strives to study how chemicals act
in the human body and the environment, and
to develop new testing and screening tools to
support risk assessment in order to produce
better scientific data and influence policy mak-
ing in 10 key areas, including exposure assess-
ment. Risk assessment, respiratory toxicology,
endocrine modulation, chemical carcinogene-
sis, endocrine modulation, immunotoxicology,
ecotoxicology, neurotoxicology, and the health
effects of HPV chemicals are also among the
research priorities, according to Henry.
The Chemical Industry Institute of
Toxicology in Research Triangle Park will
conduct much of the research for the ACC,
although university research will also be
included. Funding, the bulk of which comes
from the ACC, will run about $20 million a
year through 2003, and then increase to about
$25 million annually, Henry says. Before any
LRI projects begin, the Chemical Industry
Institute of Toxicology will seek external
review of each project by researchers at acade-
mic and federal institutions, including the
EPA and the National Institutes of Health. 
In another project, as part of improve-
ments to its 12-year-old Responsible Care ini-
tiative, the chemical industry also plans to
conduct voluntary screening tests to determine
potential health and environmental effects of
2,000 of the roughly 2,800 total HPV chemi-
cals, according to Larry W. Rampy, leader of
the ACC product stewardship team. The vol-
untary program is largely the result of a 1997
challenge by Environmental Defense (formerly
the Environmental Defense Fund) to make
adequate risk data publically available. The
goal is to complete testing of the 2,000 chemi-
cals by 2004 at an estimated cost of $300–500
million. Testing on some 1,000 chemicals
should be completed this year, provided ongo-
ing conflicts with animal rights activists who
object to using animals as test subjects are
ironed out, Rampy says. 
The Organisation for Economic Co-
operation and Development established a
cooperative international program for screen-
ing HPV chemicals a decade ago, but little
progress was made until recent years. To date
approximately 500 HPV chemicals have been
tested under this program. In 1998, Vice
President Al Gore unveiled the Chemical
Right-to-Know Initiative, which included a
challenge to voluntarily complete screening
information data sets on the 2,800 HPV
chemicals or face mandatory testing under the
Toxic Substances Control Act. A voluntary
testing arrangement, the EPA’s HPV
Challenge Program, was developed by the
ACC, Environmental Defense, and the EPA.
Although the EPA plans to mandate tests for
HPV chemicals if industry doesn’t volunteer,
the regulations haven’t been promulgated yet.
The ACC is also working to improve
communication of available environmental,
health, and safety data, largely to comply with
federal rules. In March 2000, 14 chemical
firms and associations, including the ACC,
formed the Alliance for Chemical Awareness
to disseminate chemical data to the public.
Initially, the alliance will focus on chemicals
being tested as part of the HPV Challenge
Program. The alliance is seeking more involve-
ment from government and academic stake-
holders. However, disputes continue between
the EPA and the ACC over exactly how infor-
mation should be disseminated—the EPA
intends to make all HPV testing data public,
while many chemical companies fear that risks
could be mischaracterized by environmental
groups. The ACC is also in the process of
developing an electronic tracking system that
will allow the public and test sponsors to fol-
low progress in the HPV testing program via
the Internet.
Federal Tracking Improvements
Will the next exposure-related crisis be caught
earlier than the Libby situation was? It’s hard
to predict. 
Current disease tracking efforts are sketchy
at best. Most states don’t track autoimmune
diseases such as lupus, endocrine and metabol-
ic disorders such as diabetes, neurologic condi-
tions such as migraines and multiple sclerosis,
or developmental disabilities such as autism,
cerebral palsy, and mental retardation, despite
the fact that all are on the rise. Less than half
of states track asthma cases.
One of the leading ideas for plugging gaps
in the environmental health body of knowledge
is the creation of a national health tracking net-
work. Proponents, which include Pew
Commission researchers and more than a dozen
national public health organizations such as the
American Cancer Society and the American
Public Health Association, contend that such a
system would help link diseases with exposure,
and exposure assessment with disease etiology,
disease prevention, and genetic vulnerability to
environmental agents. This would, in turn, pro-
tect Americans from often fatal or debilitating
chronic diseases. Estimates for creating such a
network run to about $275 million. 
The idea of building a network has already
attracted some attention from Congress and
the White House. In July 2000, Gore told the
Children’s Environmental Health Network
that he supported the establishment by 2004
of a national tracking system for asthma, can-
cer, and other diseases afflicting children that
are potentially linked to environmental causes.
The system would use the Internet to facilitate
information collection by local public health
agencies and health care providers, which
would help focus efforts to address environ-
mental health risks.
Such a network might have mitigated the
tragedy in Libby. “Active tracking of environ-
mental disease might have picked [the disease
cases] up much sooner, and started preventive
activities decades earlier,” says Campolucci.
“We need an environmental surveillance sys-
tem that evaluates human health.” Adds
O’Hara, “All too often we haven’t had all the
exposure information we need to make good
policy.” But better coordination and expan-
sion of human exposure assessment programs
at the federal level and by industry should help
fill the gaps, leading to better policies—and
healthier people. 
Julie Wakefield
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